Nausea, vomiting, diarrhea, and constipation topped the list, particularly during dose escalation
It is important for users to maintain regular contact with their healthcare provider, who can offer personalized medical advice tailored to individual health profiles
In December 2025, WW launched a standalone GLP-1 Success program for members whose prescriptions come from outside providers, positioning the company as the support layer around GLP-1s regardless of where the script originates
Inspection report (Form FDA 483) sent October 10, 2024FDA Warning: Drug products failed to meet the requirements of approved outsourcing facilities under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act)
The guidance produced by the MHRA is sensible, since it highlights that women could accidentally get pregnant when taking GLP-1 drugs